Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 0.71 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.65 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.65 |
| ▸ | ESR1 | P03372 | 2/20 | 0.65 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.65 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.65 |
| ▸ | AHR | P35869 | 2/20 | 0.65 |
| ▸ | ABL1 | P00519 | 1/20 | 0.65 |
| ▸ | TTR | P02766 | 1/20 | 0.65 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.65 |
| ▸ | BCR | P11274 | 1/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.65 |
| ▸ | NQO2 | P16083 | 1/20 | 0.65 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.65 |
| ▸ | TUBB | P07437 | 1/20 | 0.65 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5496071 | 1.00 | RELA (1.00) | RELAACHETRPA1CYP1A2CYP1A1 | |
| SCHEMBL10097227 | 1.00 | RELA (1.00) | RELAACHETRPA1CYP1A2CYP1A1 | |
| SCHEMBL14947047 | 1.00 | RELA (1.00) | RELAACHETRPA1CYP1A2CYP1A1 | |
| SCHEMBL2622580 | 0.91 | RELA (0.83) | RELAACHETRPA1CYP1A2CYP1A1 | |
| SCHEMBL699458 | 0.90 | RELA (0.81) | RELATRPA1CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL631998 | 0.90 | RELA (0.81) | RELATRPA1CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL14950253 | 0.90 | RELA (0.81) | RELATRPA1CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL4881152 | 0.90 | RELA (0.81) | RELATRPA1CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL13790336 | 0.90 | RELA (0.81) | RELATRPA1CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL699457 | 0.90 | RELA (0.81) | RELATRPA1CYP1A2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8980954-B2 | Substituted cis- and trans-stilbenes as therapeutic agents | STC.UNM (US) | 2015-03-17 | — | — | US | claimed |
| EP-3116851-B1 | ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING | SALK INST FOR BIOLOGICAL STUDI (US) | 2023-07-26 | — | — | EP | disclosed |
| EP-3964495-A1 | MOLECULES HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETO | Dow AgroSciences LLC (US) | 2022-03-09 | — | — | EP | disclosed |
| US-9925153-B2 | Therapeutic agents for skin diseases and conditions | STC.UNM (US) | 2018-03-27 | — | — | US | disclosed |
| US-9925153-B2 | Therapeutic agents for skin diseases and conditions | STC.UNM (US) | 2018-03-27 | — | — | US | disclosed |
| WO-2018026643-A1 | POLYMER NANOPARTICLE, POLYMER COMPOSITION, METHOD OF MAKING A POLYMER NANOPARTICLE, METHOD FOR TREATMENT OF BACTERIAL BIOFILMS, AND METHOD FOR DETECTION OF BACTERIAL BIOFILMS | THE UNIVERSITY OF MASSACHUSETTS (US) | 2018-02-08 | — | — | WO | disclosed |
| US-20180021303-A1 | BKCA CHANNEL ACTIVATOR FOR TREATING MUSCULAR DISORDER | CANBEX THERAPEUTICS LTD (GB) | 2018-01-25 | — | — | US | disclosed |
| US-20170362152-A1 | NOVEL 1,2-DIPHENYLETHYLENE GLYCOL COMPOUNDS FOR COMBATING AGING OF THE SKIN, AND COSMETIC USE THEREOF | L'OREAL (FR) | 2017-12-21 | — | — | US | disclosed |
| WO-2017078927-A1 | ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2017-05-11 | — | — | WO | disclosed |
| US-9616099-B2 | Cyclosporin analogues for preventing or treating hepatitis C infection | ENANTA PHARMACEUTICALS, INC. (US) | 2017-04-11 | — | — | US | disclosed |
| US-8193528-B2 | Azapyrenes for electronic applications | BASF SE (DE) | 2012-06-05 | — | — | US | disclosed |
| US-8193528-B2 | Azapyrenes for electronic applications | BASF SE (DE) | 2012-06-05 | — | — | US | disclosed |
| US-20110186821-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2011-08-04 | — | — | US | disclosed |
| US-20110186821-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2011-08-04 | — | — | US | disclosed |
| US-20090192154-A1 | SULTAM DERIVATIVES | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-07-30 | — | — | US | disclosed |
| US-20070249647-A1 | Substituted CIS- and trans-stilbenes as therapeutic agents | REGENTS OF THE UNIVERSITY OF NEW MEXICO | 2007-10-25 | — | — | US | disclosed |
| US-20070249647-A1 | Substituted CIS- and trans-stilbenes as therapeutic agents | REGENTS OF THE UNIVERSITY OF NEW MEXICO | 2007-10-25 | — | — | US | disclosed |
| US-20070249647-A1 | Substituted CIS- and trans-stilbenes as therapeutic agents | REGENTS OF THE UNIVERSITY OF NEW MEXICO | 2007-10-25 | — | — | US | disclosed |
| US-7201976-B2 | Organic electroluminescence material and electroluminescence device using the same | SAMSUNG SDI CO., LTD. (KR) | 2007-04-10 | — | — | US | disclosed |
| US-7201976-B2 | Organic electroluminescence material and electroluminescence device using the same | SAMSUNG SDI CO., LTD. (KR) | 2007-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180021303-A1 | BKCA CHANNEL ACTIVATOR FOR TREATING MUSCULAR DISORDER | KCNMA1, KCNMB1, KCNA1 | RELA 3172/4885ACHE 479/4885TRPA1 246/4885 |
| US-20110186821-A1 | AZAPYRENES FOR ELECTRONIC APPLICATIONS | RPS4Y1, NPY4R, XPO4 | RELA 3259/4885ACHE 2710/4885TRPA1 1801/4885 |
| US-20070249647-A1 | Substituted CIS- and trans-stilbenes as therapeutic agents | TGFB1, VHL, TMSB10 | RELA 12/4885ACHE 1869/4885TRPA1 1533/4885 |
| US-20170362152-A1 | NOVEL 1,2-DIPHENYLETHYLENE GLYCOL COMPOUNDS FOR COMBATING AGING OF THE SKIN, AND COSMETIC USE THEREOF | GLA, DSG1, GPX1 | RELA 2682/4885ACHE 2088/4885TRPA1 703/4885 |
| US-20090192154-A1 | SULTAM DERIVATIVES | SULT1A1, SULT2A1, ADAMTS1 | RELA 1753/4885ACHE 616/4885TRPA1 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.